Quantitation of HIV-1 RNA in Dried Plasma Spots (DPS): A Field Approach to Therapeutic Monitoring

The ability to measure accurately viral RNA in the plasma (1 –3 ) and intracellular (4 –7 ) compartments of HIV-1-infected persons has led to a dramatic improvement in our understanding of the natural history of HIV-1/AIDS. A number of recent studies have convincingly demonstrated that high levels of viral replication occur at all stages of disease (8 –10 ), and that changes in viral RNA load are predictive of disease outcome (11 ,12 ) and response to therapy (13 ,14 ). These findings, combined with the introduction of potent new antivirals (15 ,16 ), have stimulated a growing interest in viral load monitoring, both as a function of disease status, and as a predictor of disease progression and therapeutic efficacy.